Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial
Open Access
- 1 March 2017
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 185, 43-51
- https://doi.org/10.1016/j.ahj.2016.10.025
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death in SubgroupsAnnals of Internal Medicine, 2014
- Role of Antiarrhythmic Drugs: Frequent Implantable Cardioverter-Defibrillator Shocks, Risk of Proarrhythmia, and New Drug TherapyHeart Failure Clinics, 2011
- An Updated Review of Implantable Cardioverter/Defibrillators, Induced Anxiety, and Quality of LifeHeart Failure Clinics, 2011
- Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical TrialJournal of the American College of Cardiology, 2008
- Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial IICirculation, 2006
- Mortality, Morbidity, and Complications in 3,344 Patients with Implantable Cardioverter Defibrillators:Pacing and Clinical Electrophysiology, 2003
- Effectiveness of implantable defibrillators for preventing arrhythmic events and death: A Meta-AnalysisJournal of the American College of Cardiology, 2003
- Meta-analysis of the implantable cardioverter defibrillator secondary prevention trialsEuropean Heart Journal, 2000
- Patients' Attitudes Toward Implanted Defibrillator ShocksPacing and Clinical Electrophysiology, 2000
- Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillatorHeart & Lung, 1995